TP53 Mutation and Complex Karyotype Portends a Dismal Prognosis in Patients With Mantle Cell Lymphoma von Obr, Aleš, Procházka, Vít, Jirkuvová, Andrea, Urbánková, Helena, Kriegova, Eva, Schneiderová, Petra, Vatolíková, Michaela, Papajík, Tomáš

Volltext

Ibrutinib in Mantle Cell Lymphoma Patients: Analysis of the Czech Lymphoma Study Group von Obr, Aleš, Klener, Pavel, Janíková, Andrea, Mocikova, Heidi, Belada, David, Šálek, David, Sýkorová, Alice, Jirkuvová, Andrea, Papajík, Tomáš, Trněný, Marek

Volltext

Current perspective on diagnosis and treatment of primary central nervous system lymphomas von Jirkuvová, Andrea, Procházka, Vít, Obr, Aleš

Volltext

A high TP53 mutation burden is a strong predictor of primary refractory mantle cell lymphoma von Obr, Ales, Klener, Pavel, Furst, Tomas, Kriegova, Eva, Zemanova, Zuzana, Urbankova, Helena, Jirkuvova, Andrea, Petrackova, Anna, Malarikova, Diana, Forsterova, Kristina, Cudova, Barbora, Sedlarikova, Lenka, Berkova, Adela, Kasalova, Nela, Papajik, Tomas, Trneny, Marek

Volltext

High TP53 Mutation Load Predicts Primary Refractory Mantle Cell Lymphoma von Obr, Aleš, Klener, Pavel, Kriegova, Eva, Zemanova, Zuzana, Urbankova, Helena, Jirkuvova, Andrea, Petrackova, Anna, Cudova, Barbora, Sedlarikova, Lenka, Prochazka, VIT K, Papajik, Tomas, Trneny, Marek

Volltext